Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NutraMax sales up 17.2% to $94.3 mil. in FY 1997, net income down 60%.

This article was originally published in The Tan Sheet

Executive Summary

NUTRAMAX ANNUAL SALES UP 17.2% TO $94.3 MIL, NET INCOME FALLS 60% to $2.3 mil. in the fiscal year ended Sept. 27, compared to earnings of $5.7 mil. in the previous fiscal year (ended Sept. 30, 1996), the private label H&BA company reported Nov. 19. NutraMax had expected the net income decline; the firm announced Oct. 14 that production and distribution problems in its largest segment -- cough/cold products -- would result in a fourth quarter net loss and lower year-end results ("The Tan Sheet" Oct. 20, p. 16). In the fourth quarter, NutraMax recorded a $1 mil. net loss on sales of $24.1 mil., which were up 7.5%.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel